
Brian E. Mcdowell
Examiner (ID: 2181, Phone: (571)270-5755 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 4161, 1624 |
| Total Applications | 1622 |
| Issued Applications | 1025 |
| Pending Applications | 135 |
| Abandoned Applications | 522 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10799060
[patent_doc_number] => 20160145217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'METHOD FOR PREPARING NITROGEN-CONTAINING AROMATIC COMPOUND BY CATALYTIC PYROLYSIS OF ORGANIC MATERIAL'
[patent_app_type] => utility
[patent_app_number] => 15/009499
[patent_app_country] => US
[patent_app_date] => 2016-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22923
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15009499
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/009499 | Method for preparing nitrogen-containing aromatic compound by catalytic pyrolysis of organic material | Jan 27, 2016 | Issued |
Array
(
[id] => 15915221
[patent_doc_number] => 10654839
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => Compositions and methods for viral sensitization
[patent_app_type] => utility
[patent_app_number] => 15/546167
[patent_app_country] => US
[patent_app_date] => 2016-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 27
[patent_no_of_words] => 13622
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15546167
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/546167 | Compositions and methods for viral sensitization | Jan 25, 2016 | Issued |
Array
(
[id] => 12092503
[patent_doc_number] => 20170349594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'BIARYL DERIVATIVE AS GPR120 AGONIST'
[patent_app_type] => utility
[patent_app_number] => 15/539310
[patent_app_country] => US
[patent_app_date] => 2015-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 199585
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539310
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/539310 | Biaryl derivative as GPR120 agonist | Dec 22, 2015 | Issued |
Array
(
[id] => 10760602
[patent_doc_number] => 20160106756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-21
[patent_title] => 'BENZODIAZEPINES FOR TREATING SMALL CELL LUNG CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/975928
[patent_app_country] => US
[patent_app_date] => 2015-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3487
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14975928
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/975928 | BENZODIAZEPINES FOR TREATING SMALL CELL LUNG CANCER | Dec 20, 2015 | Abandoned |
Array
(
[id] => 14169267
[patent_doc_number] => 10258620
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-16
[patent_title] => Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said form
[patent_app_type] => utility
[patent_app_number] => 15/536634
[patent_app_country] => US
[patent_app_date] => 2015-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 18
[patent_no_of_words] => 13595
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15536634
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/536634 | Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said form | Dec 17, 2015 | Issued |
Array
(
[id] => 13970409
[patent_doc_number] => 10214546
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-26
[patent_title] => Btk inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/538971
[patent_app_country] => US
[patent_app_date] => 2015-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48661
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 267
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15538971
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/538971 | Btk inhibitors | Dec 16, 2015 | Issued |
Array
(
[id] => 12092500
[patent_doc_number] => 20170349593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'BTK INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/538966
[patent_app_country] => US
[patent_app_date] => 2015-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32006
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15538966
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/538966 | BTK INHIBITORS | Dec 16, 2015 | Abandoned |
Array
(
[id] => 10749692
[patent_doc_number] => 20160095844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-07
[patent_title] => 'INDOLIN-2-ONE OR PYRROLO-PYRIDIN/PYRIMIDIN-2-ONE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/971120
[patent_app_country] => US
[patent_app_date] => 2015-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 46250
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14971120
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/971120 | Indolin-2-one or pyrrolo-pyridin/pyrimidin-2-one derivatives | Dec 15, 2015 | Issued |
Array
(
[id] => 12975505
[patent_doc_number] => 20170340584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => MODIFIED TAURINE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASES CONTAINING SAME
[patent_app_type] => utility
[patent_app_number] => 15/535212
[patent_app_country] => US
[patent_app_date] => 2015-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16762
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15535212
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/535212 | MODIFIED TAURINE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASES CONTAINING SAME | Dec 15, 2015 | Abandoned |
Array
(
[id] => 12980194
[patent_doc_number] => 20170342272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => COMPOSITE PHTHALOCYANINE MICROPARTICLES AND METHOD FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 15/535966
[patent_app_country] => US
[patent_app_date] => 2015-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17894
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15535966
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/535966 | Composite phthalocyanine microparticles and method for producing same | Dec 14, 2015 | Issued |
Array
(
[id] => 13699543
[patent_doc_number] => 20170360726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => COMPOUNDS, COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 15/533354
[patent_app_country] => US
[patent_app_date] => 2015-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24307
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15533354
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/533354 | COMPOUNDS, COMPOSITIONS AND METHODS OF USE | Dec 3, 2015 | Abandoned |
Array
(
[id] => 12049916
[patent_doc_number] => 20170326261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-16
[patent_title] => 'BIFUNCTIONAL do2pa DERIVATIVES, CHELATES WITH METALLIC CATIONS AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/533204
[patent_app_country] => US
[patent_app_date] => 2015-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12916
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15533204
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/533204 | BIFUNCTIONAL do2pa DERIVATIVES, CHELATES WITH METALLIC CATIONS AND USE THEREOF | Dec 3, 2015 | Abandoned |
Array
(
[id] => 10761895
[patent_doc_number] => 20160108049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-21
[patent_title] => 'Novel Phthalazinone-Pyrrolopyrimidinecarboxamide Derivatives'
[patent_app_type] => utility
[patent_app_number] => 14/958141
[patent_app_country] => US
[patent_app_date] => 2015-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 80742
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14958141
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/958141 | Novel Phthalazinone-Pyrrolopyrimidinecarboxamide Derivatives | Dec 2, 2015 | Abandoned |
Array
(
[id] => 13137379
[patent_doc_number] => 10086000
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-02
[patent_title] => Tricyclic compounds as inhibitors of mutant IDH enzymes
[patent_app_type] => utility
[patent_app_number] => 15/532548
[patent_app_country] => US
[patent_app_date] => 2015-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26773
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 756
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15532548
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/532548 | Tricyclic compounds as inhibitors of mutant IDH enzymes | Nov 30, 2015 | Issued |
Array
(
[id] => 13763373
[patent_doc_number] => 10174021
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-08
[patent_title] => Substituted pyrazolo[1,5-A]pyridines and their use
[patent_app_type] => utility
[patent_app_number] => 15/531993
[patent_app_country] => US
[patent_app_date] => 2015-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27857
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 814
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15531993
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/531993 | Substituted pyrazolo[1,5-A]pyridines and their use | Nov 29, 2015 | Issued |
Array
(
[id] => 11647732
[patent_doc_number] => 20170143633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'NANOPARTICLES, METHOD OF PREPARING THE SAME AND THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 14/945723
[patent_app_country] => US
[patent_app_date] => 2015-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3964
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14945723
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/945723 | Nanoparticles, method of preparing the same and their use | Nov 18, 2015 | Issued |
Array
(
[id] => 13870683
[patent_doc_number] => 20190031682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => DIFLUOROMETHYL-AMINOPYRIDINES AND DIFLUOROMETHYL-AMINOPYRIMIDINES
[patent_app_type] => utility
[patent_app_number] => 15/525779
[patent_app_country] => US
[patent_app_date] => 2015-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32722
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15525779
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/525779 | Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines | Nov 9, 2015 | Issued |
Array
(
[id] => 10791495
[patent_doc_number] => 20160137651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-19
[patent_title] => 'PYRAZOLOPYRIMIDINE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/926977
[patent_app_country] => US
[patent_app_date] => 2015-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15473
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14926977
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/926977 | Pyrazolopyrimidine compounds | Oct 28, 2015 | Issued |
Array
(
[id] => 12177342
[patent_doc_number] => 20180036277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'C14-HYDROXYL ESTERIFIED AMINO ACID DERIVATIVE OF TRIPTOLIDE, AND PREPARATION METHOD AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/551695
[patent_app_country] => US
[patent_app_date] => 2015-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13996
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15551695
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/551695 | C14-hydroxyl esterified amino acid derivative of triptolide, and preparation method and use thereof | Oct 28, 2015 | Issued |
Array
(
[id] => 12945532
[patent_doc_number] => 09834550
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-05
[patent_title] => Pyridopyrimidinone compounds for modulating the catalytic activity of histone lysine demethylases (KDMs)
[patent_app_type] => utility
[patent_app_number] => 14/923525
[patent_app_country] => US
[patent_app_date] => 2015-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 29331
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 250
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14923525
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/923525 | Pyridopyrimidinone compounds for modulating the catalytic activity of histone lysine demethylases (KDMs) | Oct 26, 2015 | Issued |